E
bioAffinity Technologies, Inc. BIAF
$0.2872 -$0.0088-2.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -9.74M -9.04M -8.45M -8.74M -8.37M
Total Depreciation and Amortization 610.60K 605.60K 600.80K 507.10K 377.60K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.03M 989.70K 990.10K 990.80K 874.90K
Change in Net Operating Assets 1.53M 179.70K -348.70K 211.10K 258.90K
Cash from Operations -6.56M -7.26M -7.20M -7.03M -6.85M
Capital Expenditure -88.50K -79.10K -65.70K -56.50K -32.10K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 0.00 -2.19M -2.19M
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -88.50K -79.10K -65.70K -2.24M -2.22M
Total Debt Issued 164.10K 191.80K 288.70K 26.80K 27.70K
Total Debt Repaid -411.60K -361.10K -354.90K -314.70K -350.40K
Issuance of Common Stock 4.89M 6.29M 4.08M 2.57M 2.57M
Repurchase of Common Stock -494.90K -494.90K -494.90K -494.90K --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 495.00K 0.00 0.00 0.00 -495.00K
Cash from Financing 4.64M 5.63M 3.52M 1.79M 1.76M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -2.01M -1.72M -3.75M -7.48M -7.32M